Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

NCT04999969 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Solid Tumours

Interventions

DRUG: AZD0171
DRUG: Durvalumab
DRUG: Gemcitabine
DRUG: Nab-paclitaxel

Sponsor

AstraZeneca